Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)

Patrick Y. Wen, Timothy F. Cloughesy, Benjamin M. Ellingson, David A. Reardon, Howard A. Fine, Lauren Abrey, Karla Ballman, Martin Bendszuz, Jan Craig Buckner, Susan M. Chang, Michael D. Prados, Whitney B. Pope, Alma Gregory Sorensen, Martin van den Bent, Wai Kwan A lfred Yung

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.

Original languageEnglish (US)
Pages (from-to)vii36-vii47
JournalNeuro-Oncology
Volume16
DOIs
StatePublished - Oct 1 2014

Fingerprint

Neuroimaging
Brain Neoplasms
Clinical Trials
Education
Pharmaceutical Preparations
Patient Advocacy
National Cancer Institute (U.S.)
United States Food and Drug Administration
Research
Glioma
Industry
Organizations

Keywords

  • brain tumor
  • endpoints
  • neuroimaging
  • RANO
  • workshop

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wen, P. Y., Cloughesy, T. F., Ellingson, B. M., Reardon, D. A., Fine, H. A., Abrey, L., ... Yung, W. K. A. L. (2014). Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro-Oncology, 16, vii36-vii47. https://doi.org/10.1093/neuonc/nou226

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). / Wen, Patrick Y.; Cloughesy, Timothy F.; Ellingson, Benjamin M.; Reardon, David A.; Fine, Howard A.; Abrey, Lauren; Ballman, Karla; Bendszuz, Martin; Buckner, Jan Craig; Chang, Susan M.; Prados, Michael D.; Pope, Whitney B.; Gregory Sorensen, Alma; van den Bent, Martin; Yung, Wai Kwan A lfred.

In: Neuro-Oncology, Vol. 16, 01.10.2014, p. vii36-vii47.

Research output: Contribution to journalArticle

Wen, PY, Cloughesy, TF, Ellingson, BM, Reardon, DA, Fine, HA, Abrey, L, Ballman, K, Bendszuz, M, Buckner, JC, Chang, SM, Prados, MD, Pope, WB, Gregory Sorensen, A, van den Bent, M & Yung, WKAL 2014, 'Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)', Neuro-Oncology, vol. 16, pp. vii36-vii47. https://doi.org/10.1093/neuonc/nou226
Wen, Patrick Y. ; Cloughesy, Timothy F. ; Ellingson, Benjamin M. ; Reardon, David A. ; Fine, Howard A. ; Abrey, Lauren ; Ballman, Karla ; Bendszuz, Martin ; Buckner, Jan Craig ; Chang, Susan M. ; Prados, Michael D. ; Pope, Whitney B. ; Gregory Sorensen, Alma ; van den Bent, Martin ; Yung, Wai Kwan A lfred. / Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). In: Neuro-Oncology. 2014 ; Vol. 16. pp. vii36-vii47.
@article{150503aacf8447589ff92ecfbb40b571,
title = "Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)",
abstract = "On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.",
keywords = "brain tumor, endpoints, neuroimaging, RANO, workshop",
author = "Wen, {Patrick Y.} and Cloughesy, {Timothy F.} and Ellingson, {Benjamin M.} and Reardon, {David A.} and Fine, {Howard A.} and Lauren Abrey and Karla Ballman and Martin Bendszuz and Buckner, {Jan Craig} and Chang, {Susan M.} and Prados, {Michael D.} and Pope, {Whitney B.} and {Gregory Sorensen}, Alma and {van den Bent}, Martin and Yung, {Wai Kwan A lfred}",
year = "2014",
month = "10",
day = "1",
doi = "10.1093/neuonc/nou226",
language = "English (US)",
volume = "16",
pages = "vii36--vii47",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)

AU - Wen, Patrick Y.

AU - Cloughesy, Timothy F.

AU - Ellingson, Benjamin M.

AU - Reardon, David A.

AU - Fine, Howard A.

AU - Abrey, Lauren

AU - Ballman, Karla

AU - Bendszuz, Martin

AU - Buckner, Jan Craig

AU - Chang, Susan M.

AU - Prados, Michael D.

AU - Pope, Whitney B.

AU - Gregory Sorensen, Alma

AU - van den Bent, Martin

AU - Yung, Wai Kwan A lfred

PY - 2014/10/1

Y1 - 2014/10/1

N2 - On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.

AB - On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.

KW - brain tumor

KW - endpoints

KW - neuroimaging

KW - RANO

KW - workshop

UR - http://www.scopus.com/inward/record.url?scp=84965187416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965187416&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nou226

DO - 10.1093/neuonc/nou226

M3 - Article

C2 - 25313237

AN - SCOPUS:84965187416

VL - 16

SP - vii36-vii47

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

ER -